Significant Customers and Concentration of Credit Risk (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2014
products
dosing_strength
|
Jun. 30, 2014
Sales Revenue, Product Line [Member]
Customer A [Member]
|
Jun. 30, 2013
Sales Revenue, Product Line [Member]
Customer A [Member]
|
Jun. 30, 2014
Sales Revenue, Product Line [Member]
Customer A [Member]
|
Jun. 30, 2013
Sales Revenue, Product Line [Member]
Customer A [Member]
|
Jun. 30, 2014
Sales Revenue, Product Line [Member]
Customer B [Member]
|
Jun. 30, 2013
Sales Revenue, Product Line [Member]
Customer B [Member]
|
Jun. 30, 2014
Sales Revenue, Product Line [Member]
Customer B [Member]
|
Jun. 30, 2013
Sales Revenue, Product Line [Member]
Customer B [Member]
|
Jun. 30, 2014
Sales Revenue, Product Line [Member]
Customer C [Member]
|
Jun. 30, 2013
Sales Revenue, Product Line [Member]
Customer C [Member]
|
Jun. 30, 2014
Sales Revenue, Product Line [Member]
Customer C [Member]
|
Jun. 30, 2013
Sales Revenue, Product Line [Member]
Customer C [Member]
|
Jun. 30, 2014
Sales Revenue, Product Line [Member]
Customer D [Member]
|
Jun. 30, 2013
Sales Revenue, Product Line [Member]
Customer D [Member]
|
Jun. 30, 2014
Sales Revenue, Product Line [Member]
Customer D [Member]
|
Jun. 30, 2013
Sales Revenue, Product Line [Member]
Customer D [Member]
|
Jun. 30, 2014
Sales Revenue, Product Line [Member]
Customer E [Member]
|
Jun. 30, 2013
Sales Revenue, Product Line [Member]
Customer E [Member]
|
Jun. 30, 2014
Sales Revenue, Product Line [Member]
Customer E [Member]
|
Jun. 30, 2013
Sales Revenue, Product Line [Member]
Customer E [Member]
|
Jun. 30, 2014
Accounts Receivable [Member]
Customer A [Member]
|
Dec. 31, 2013
Accounts Receivable [Member]
Customer A [Member]
|
Jun. 30, 2014
Accounts Receivable [Member]
Customer B [Member]
|
Dec. 31, 2013
Accounts Receivable [Member]
Customer B [Member]
|
Jun. 30, 2014
Accounts Receivable [Member]
Customer C [Member]
|
Dec. 31, 2013
Accounts Receivable [Member]
Customer C [Member]
|
Jun. 30, 2014
Accounts Receivable [Member]
Customer D [Member]
|
Dec. 31, 2013
Accounts Receivable [Member]
Customer D [Member]
|
|
Concentration Risk [Line Items] | |||||||||||||||||||||||||||||
Number of Commerical Products | 1 | ||||||||||||||||||||||||||||
Number of Dosing Strengths | 6 | ||||||||||||||||||||||||||||
Concentration Risk, Percentage | 38.00% | 0.00% | 45.00% | 0.00% | 31.00% | 0.00% | 22.00% | 0.00% | 7.00% | 0.00% | 10.00% | 0.00% | 14.00% | 0.00% | 8.00% | 0.00% | 5.00% | 0.00% | 10.00% | 0.00% | 28.00% | 25.00% | 45.00% | 11.00% | 6.00% | 54.00% | 11.00% | 7.00% | |
Gross Revenue of Significant Order | $ 1.5 | ||||||||||||||||||||||||||||
Net Revenue of Significant Order | $ 0.9 |